window.protocolData = window.protocolData || {};
window.protocolData.thyroid = {
  "differentiated": {
    "metastatic": {
      "Lenvatinib-DTC": {
        "name": "Lenvatinib (SELECT) (NCCN Preferred)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Lenvatinib",
            "dose": 24,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Sorafenib-DTC": {
        "name": "Sorafenib (DECISION)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Sorafenib",
            "dose": 400,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Cabozantinib-DTC": {
        "name": "Cabozantinib (COSMIC-311) (post-VEGFR-targeted therapy)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Cabozantinib",
            "dose": 60,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Selpercatinib-RET-DTC": {
        "name": "Selpercatinib (RET inhibitor) (RET gene fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Selpercatinib",
            "dose": 160,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Pralsetinib-RET-DTC": {
        "name": "Pralsetinib (RET inhibitor) (RET gene fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Pralsetinib",
            "dose": 400,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Larotrectinib-NTRK-DTC": {
        "name": "Larotrectinib (TRK inhibitor) (NTRK gene fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Larotrectinib",
            "dose": 100,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Entrectinib-NTRK-DTC": {
        "name": "Entrectinib (TRK inhibitor) (NTRK gene fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Entrectinib",
            "dose": 600,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Repotrectinib-NTRK-DTC": {
        "name": "Repotrectinib (TRK inhibitor) (NTRK gene fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Repotrectinib",
            "dose": 160,
            "unit": "mg",
            "schedule": "PO once daily x 14 days, then 160 mg PO twice daily, until progression"
          }
        ]
      },
      "Dabrafenib-Trametinib-DTC": {
        "name": "Dabrafenib + Trametinib (BRAF/MEK inhibitors) (BRAF V600E-mutant)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Dabrafenib",
            "dose": 150,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          },
          {
            "name": "Trametinib",
            "dose": 2,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Pembrolizumab-Lenvatinib-DTC": {
        "name": "Pembrolizumab + Lenvatinib (post-lenvatinib progression)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Pembrolizumab",
            "dose": 200,
            "unit": "mg",
            "schedule": "D1, every 21 days (or 400 mg every 42 days), until progression"
          },
          {
            "name": "Lenvatinib",
            "dose": 20,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Pemetrexed-Carboplatin-DTC": {
        "name": "Pemetrexed + Carboplatin",
        "cycles": 6,
        "drugs": [
          {
            "name": "Pemetrexed",
            "dose": 500,
            "unit": "mg/m²",
            "schedule": "D1, every 21 days"
          },
          {
            "name": "Carboplatin",
            "dose": "AUC 5",
            "unit": "AUC",
            "schedule": "D1, every 21 days"
          }
        ]
      }
    }
  },
  "medullary": {
    "metastatic": {
      "Selpercatinib-RET-MTC": {
        "name": "Selpercatinib (LIBRETTO-531) (RET inhibitor) (RET-mutant) (NCCN Preferred)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Selpercatinib",
            "dose": 160,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Vandetanib-MTC": {
        "name": "Vandetanib (multi-kinase inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Vandetanib",
            "dose": 300,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Cabozantinib-MTC": {
        "name": "Cabozantinib (multi-kinase inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Cabozantinib",
            "dose": 140,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Sorafenib-MTC": {
        "name": "Sorafenib (multi-kinase inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Sorafenib",
            "dose": 400,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Lenvatinib-MTC": {
        "name": "Lenvatinib (multi-kinase inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Lenvatinib",
            "dose": 24,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Sunitinib-MTC": {
        "name": "Sunitinib (multi-kinase inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Sunitinib",
            "dose": 50,
            "unit": "mg",
            "schedule": "PO daily for 4 weeks, then 2 weeks off (6-week cycles), until progression"
          }
        ]
      },
      "Larotrectinib-NTRK-MTC": {
        "name": "Larotrectinib (TRK inhibitor) (NTRK gene fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Larotrectinib",
            "dose": 100,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Entrectinib-NTRK-MTC": {
        "name": "Entrectinib (TRK inhibitor) (NTRK gene fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Entrectinib",
            "dose": 600,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Pembrolizumab-TMB-MTC": {
        "name": "Pembrolizumab (PD-1 inhibitor) (TMB-H ≥10 mut/Mb)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Pembrolizumab",
            "dose": 200,
            "unit": "mg",
            "schedule": "D1, every 21 days (or 400 mg every 42 days), until progression"
          }
        ]
      },
      "Dacarbazine-MTC": {
        "name": "Dacarbazine (limited evidence, late-line)",
        "cycles": 6,
        "drugs": [
          {
            "name": "Dacarbazine",
            "dose": 250,
            "unit": "mg/m²",
            "schedule": "D1-D5, every 28 days"
          }
        ]
      }
    }
  },
  "anaplastic": {
    "metastatic": {
      "Dabrafenib-Trametinib-ATC": {
        "name": "Dabrafenib + Trametinib (BRAF/MEK inhibitors) (BRAF V600E-mutant) (NCCN Preferred)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Dabrafenib",
            "dose": 150,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          },
          {
            "name": "Trametinib",
            "dose": 2,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Selpercatinib-RET-ATC": {
        "name": "Selpercatinib (RET inhibitor) (RET-altered)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Selpercatinib",
            "dose": 160,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Pralsetinib-RET-ATC": {
        "name": "Pralsetinib (RET inhibitor) (RET fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Pralsetinib",
            "dose": 400,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Larotrectinib-NTRK-ATC": {
        "name": "Larotrectinib (TRK inhibitor) (NTRK fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Larotrectinib",
            "dose": 100,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Entrectinib-NTRK-ATC": {
        "name": "Entrectinib (TRK inhibitor) (NTRK fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Entrectinib",
            "dose": 600,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Repotrectinib-NTRK-ATC": {
        "name": "Repotrectinib (TRK inhibitor) (NTRK fusion-positive)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Repotrectinib",
            "dose": 160,
            "unit": "mg",
            "schedule": "PO once daily x 14 days, then 160 mg PO twice daily, until progression"
          }
        ]
      },
      "Lenvatinib-ATC": {
        "name": "Lenvatinib (multi-kinase inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Lenvatinib",
            "dose": 24,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Sorafenib-ATC": {
        "name": "Sorafenib (multi-kinase inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Sorafenib",
            "dose": 400,
            "unit": "mg",
            "schedule": "PO twice daily, until progression"
          }
        ]
      },
      "Cabozantinib-ATC": {
        "name": "Cabozantinib (multi-kinase inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Cabozantinib",
            "dose": 140,
            "unit": "mg",
            "schedule": "PO once daily, until progression"
          }
        ]
      },
      "Pembrolizumab-ATC": {
        "name": "Pembrolizumab (PD-1 inhibitor)",
        "cycles": 35,
        "drugs": [
          {
            "name": "Pembrolizumab",
            "dose": 200,
            "unit": "mg",
            "schedule": "D1, every 21 days (or 400 mg every 42 days), until progression (max 35 cycles)"
          }
        ]
      },
      "Doxorubicin-Cisplatin-ATC": {
        "name": "Doxorubicin + Cisplatin",
        "cycles": 6,
        "drugs": [
          {
            "name": "Doxorubicin",
            "dose": 60,
            "unit": "mg/m²",
            "schedule": "D1, every 21 days"
          },
          {
            "name": "Cisplatin",
            "dose": 40,
            "unit": "mg/m²",
            "schedule": "D1, every 21 days"
          }
        ]
      },
      "Paclitaxel-Carboplatin-ATC": {
        "name": "Paclitaxel + Carboplatin",
        "cycles": 6,
        "drugs": [
          {
            "name": "Paclitaxel",
            "dose": 175,
            "unit": "mg/m²",
            "schedule": "D1, every 21 days"
          },
          {
            "name": "Carboplatin",
            "dose": "AUC 5-6",
            "unit": "AUC",
            "schedule": "D1, every 21 days"
          }
        ]
      },
      "Paclitaxel-Weekly-ATC": {
        "name": "Paclitaxel (weekly)",
        "cycles": 6,
        "drugs": [
          {
            "name": "Paclitaxel",
            "dose": 80,
            "unit": "mg/m²",
            "schedule": "D1, D8, D15, every 28 days"
          }
        ]
      },
      "Doxorubicin-ATC": {
        "name": "Doxorubicin",
        "cycles": 6,
        "drugs": [
          {
            "name": "Doxorubicin",
            "dose": 75,
            "unit": "mg/m²",
            "schedule": "D1, every 21 days"
          }
        ]
      },
      "Docetaxel-ATC": {
        "name": "Docetaxel",
        "cycles": 6,
        "drugs": [
          {
            "name": "Docetaxel",
            "dose": 75,
            "unit": "mg/m²",
            "schedule": "D1, every 21 days"
          }
        ]
      }
    }
  }
};
